AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Gerard, CM Baudson, N Kraemer, K Ledent, C Pardoll, D Bruck, C
Citation: Cm. Gerard et al., Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice, CLIN CANC R, 7(3), 2001, pp. 838S-847S

Authors: Gerard, CM Baudson, N Kraemer, K Bruck, C Garcon, N Paterson, Y Pan, ZK Pardoll, D
Citation: Cm. Gerard et al., Therapeutic potential of protein and adjuvant vaccinations on tumour growth, VACCINE, 19(17-19), 2001, pp. 2583-2589

Authors: Pardoll, D
Citation: D. Pardoll, Immunology - T cells and tumours, NATURE, 411(6841), 2001, pp. 1010-1012

Authors: Hamad, ARA Srikrishnan, A Mirmonsef, P Broeren, CPM June, CH Pardoll, D Schneck, JP
Citation: Ara. Hamad et al., Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: Implications for autoimmunity, J EXP MED, 193(10), 2001, pp. 1113-1121

Authors: Lebowitz, MS O'Herrin, SM Hamad, ARA Fahmy, T Marguet, D Barnes, NC Pardoll, D Bieler, JG Schneck, JP
Citation: Ms. Lebowitz et al., Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: Biochemical probes for analysis and modulation of immune responses, CELL IMMUN, 192(2), 1999, pp. 175-184

Authors: Hung, K Hayashi, R Lafond-Walker, A Lowenstein, C Pardoll, D Levitsky, H
Citation: K. Hung et al., The central role of CD4(+) T cells in the antitumor immune response, J EXP MED, 188(12), 1998, pp. 2357-2368
Risultati: 1-6 |